Vissza |
Puskás László; Mán Imola; Szebeni Gábor; Tiszlavicz László; Tsai Susan; James Michael A.:
Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
MOLECULAR CANCER THERAPEUTICS, 15 (5).
pp. 985-997.
ISSN 1535-7163
(2016)